C07J 41/0077
Substituted in position 11-beta by a carbon atom, further substituted by a
Official title: {substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom}
C07J41/0077 (Substituted in position 11-beta by a carbon atom, further substituted by a) appears on 149 US grants and 88 published applications in this corpus.
Search patents in C07J- Granted patents
- 149
- Published applications
- 88
- Assignees
- 43
- Inventors
- 237
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 3 |
| 2002 | 9 | 7 |
| 2003 | 8 | 7 |
| 2004 | 6 | 5 |
| 2005 | 2 | 4 |
| 2006 | 3 | 1 |
| 2007 | 3 | 1 |
| 2008 | 1 | 0 |
| 2009 | 2 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 0 |
| 2012 | 4 | 7 |
| 2013 | 2 | 3 |
| 2014 | 1 | 3 |
| 2015 | 9 | 7 |
| 2016 | 0 | 4 |
| 2017 | 5 | 4 |
| 2018 | 3 | 2 |
| 2019 | 2 | 4 |
| 2020 | 4 | 4 |
| 2021 | 5 | 11 |
| 2022 | 1 | 1 |
| 2023 | 2 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer29 Sep 2026US 12,747,263 B2Evestra, Inc.
- Farnesoid X receptor modulators6 May 2025US 12,291,549 B2Intercept Pharmaceuticals, Inc.
- Compounds and methods for selective proteolysis of glucocorticoid receptors4 Jun 2024US 11,998,606 B2Board of Regents, The University of Texas System
- Therapeutic agents and methods18 Jul 2023US 11,702,443 B2Pop Test Oncology LLC
- Methods for onapristone synthesis dehydration and deprotection28 Mar 2023US 11,613,555 B2Context Biopharma Inc.
- Farnesoid x receptor modulators11 Dec 2025US 2025/0376488 A1
- Processes of making onapristone and intermediates thereof7 Nov 2024US 2024/0368211 A1Tyligand Bioscience (Shanghai) Limited
- Orally active leukemia inhibitory factor (lif) antagonists for the treatment of cancer18 Apr 2024US 2024/0124515 A1Evestra, Inc.
- Therapeutic agents and methods30 Nov 2023US 2023/0382945 A1Pop Test Oncology LLC
- Inhibitors of glucocorticoid receptor30 Mar 2023US 2023/0096870 A1Oric Pharmaceuticals, Inc.
Most cited
By later US patents
- Novel steroids61US 4,386,085 ARoussell Uclaf · 1983
- Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use58US 6,455,517 B1SRI International · 2002
- Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use56US 6,747,018 B2SRI International · 2004
- Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use55US 6,503,896 B1SRI International · 2003
- Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use53US 6,548,491 B2SRI International · 2003